Small Molecule Bioanalysis Services

Accelerate your drug development program with Pharmaron’s comprehensive Small Molecule Bioanalysis services, supporting every phase from discovery to market. With over 20 years of regulatory experience and cutting-edge instrumentation, we deliver precise, high-quality data for PK, TK, PD, biodistribution, and biomarker assays.

Key takeaways include:

• Discovery to Clinical Support: Rapid method development for discovery bioanalysis, GLP-compliant validation, and clinical trial logistics ensure seamless project progression.
• Advanced Capabilities: Quantitative analysis for diverse molecular structures, ultra-sensitive detection of radiolabeled compounds, and chiral method development for enantiomer separation.
• Regulatory Expertise: Successfully audited by FDA, EMA, MHRA, and more, with 30+ IND-enabling bioanalytical packages submitted annually.

Pharmaron’s state-of-the-art platforms, including 220+ LC-MS/MS systems and automated liquid handling technologies, ensure efficiency and precision.

Download the brochure today to discover how our bioanalysis solutions can drive your program forward.